Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating Anthracycline-Induced Cardiac Toxicity With Dapagliflozin: A Randomized, Double-Blind, Placebo-Controlled Trial of 10 mg Daily for Four Months

NCT06888505 is registered in ClinicalTrials.gov with Hawler Medical University as lead sponsor.

NCT NCT06888505
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06888505 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating Anthracycline-Induced Cardiac Toxicity With Dapagliflozin: A Randomized, Double-Blind, Placebo-Controlled Trial of 10 mg Daily for Four Months
Lead sponsor
Hawler Medical University
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2024
Completion date
September 6, 2025
Enrollment
94 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anthracyclines-induced cardiotoxicity, cardiotoxicity